Details of the Drug Reposition

General Information of This Drug (ID: DMZ3HD1)

Drug Name
SC-002   DMZ3HD1
Synonyms SC-004
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bacterial infection DIS5QJ9S 1A00-1C4Z Phase 1 [1]
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [2]
Small-cell lung cancer DISK3LZD 2C25.Y Phase 1 [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02500914) SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)